R1 RCM Inc. (“R1”), a leader in automating revenue management for healthcare providers, announces that investment funds affiliated with TowerBrook Capital Partners (“TowerBrook”) and Clayton, Dubilier & Rice (“CD&R”) have completed their previously announced acquisition of R1. On August 1, 2024, TowerBrook, CD&R and R1 announced that they had entered into a definitive merger agreement under which all outstanding shares of R1 common stock that TowerBrook did not own would be acquired for $14.30 per share in cash, valuing R1 at approximately $8.9 billion.
Read the full article: TowerBrook and CD&R Complete Acquisition of R1 RCM //
Source: https://www.globenewswire.com/news-release/2024/11/19/2983728/0/en/TowerBrook-and-CD-R-Complete-Acquisition-of-R1-RCM.html